Literature DB >> 6836694

Complement activation by plasma separator membranes.

B C McLeod, A Viernes, R J Sassetti.   

Abstract

Because of their structural similarity to dialysis membranes, six plasma separator membranes were evaluated for the ability to activate complement, as judged by immunoconversion of the third component of complement in crossed immunoelectrophoresis. A polysulfone and two cellulose acetate membranes were relatively strong alternative pathway activators. Polypropylene, poly[vinylidine fluoride] and polyvinyl-chloride derivative membranes were weak activators in some sera. Membrane activation was inhibited in citrate-anticoagulated but not in heparin-anticoagulated plasma. The results of such in vitro screening should be of value in selecting materials and anticoagulation regimens for membrane plasma separators.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6836694     DOI: 10.1046/j.1537-2995.1983.23283172853.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  In vitro complement activation after contact with pyrolytic carbon-coated and uncoated polyethylene terephthalate.

Authors:  E Cenni; D Granchi; G Ciapetti; S Stea; E Verri; S Gamberini; A Gori; A Pizzoferrato; P Zucchelli
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

2.  Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation.

Authors:  Ioannis Kourtzelis; Stavros Rafail; Robert A DeAngelis; Periklis G Foukas; Daniel Ricklin; John D Lambris
Journal:  FASEB J       Date:  2013-04-04       Impact factor: 5.191

3.  Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Eveline Y Wu; Elizabeth A McInnis; Sonia Boyer-Suavet; Carmen E Mendoza; Lydia T Aybar; Kristin B Kennedy; Caroline J Poulton; Candace D Henderson; Yichun Hu; Susan L Hogan; Peiqi Hu; Hong Xiao; Patrick H Nachman; J Charles Jennette; Ronald J Falk; Donna O Bunch
Journal:  Arthritis Rheumatol       Date:  2019-10-08       Impact factor: 10.995

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.